Retrospective State Medicaid Claims Analysis of Children and Adults With Obsessive-Compulsive Disorder

• Published in: Psychiatric services (Washington, D.C.) p. appips20220152
• Main Authors: Patel, Sapana R, Messner, Gabrielle R, Radigan, Marleen, Sang, Yi, Wang, Rui, Gu, Gyojeong, Myers, Robert W, Dixon, Lisa B, Simpson, H Blair
• Format: Journal Article
• Language: English
• Published: United States 01.11.2023
• Subjects: Obsessive-compulsive disorder; Prevalence; Treatment; Medicaid; Serotonin reuptake inhibitor
• ISSN: 1557-9700
• DOI: 10.1176/appi.ps.20220152

With a lifetime U.S. prevalence of 2.3%, obsessive-compulsive disorder (OCD) is a chronic condition often producing reduced quality of life and disability when left untreated. Little is known about the prevalence or treatment of diagnosed OCD in public behavioral health systems. Using a claims analysis of 2019 New York State Medicaid data (N=2,245,084 children; N=4,274,100 adults), the authors investigated the prevalence and characteristics of children and adults with OCD. The authors also examined whether these individuals received treatment with medication or psychotherapy. The prevalence of OCD was 0.2% among children and 0.3% among adults. Fewer than half of children (40.0%) and adults (37.5%) received U.S. Food and Drug Administration-approved medications (with or without psychotherapy); another 19.4% of children and 11.0% of adults received 45- or 60-minute psychotherapy alone. These data demonstrate the need for public behavioral health systems to increase their capacity to identify and treat OCD.